Battery conservation in implantable cardioverter-defibrillators and pacemakers

• US 6,766,193 B1
• Filed: 10/11/2001
• Issued: 07/20/2004
• Est. Priority Date: 10/15/1999
• Status: Expired due to Fees

• Current Assignee: Pacesetter Incorporated (Abbott Laboratories Incorporated)
• Original Assignee: Pacesetter Incorporated (Abbott Laboratories Incorporated)
• Inventors: Mouchawar, Gabriel A., Causey, James D. III
• Primary Examiner(s): EVANISKO, GEORGE ROBERT
• Application Number:
  US09/977,890
• Time in Patent Office: 1,013 Days
• Field of Search: 607/4, 607/5, 607/9, 607/16
• US Class Current: 607/9
• CPC Class Codes: A61N 1/378 Electrical supply
• CPC Class Codes: A61N 1/3956 Implantable devices for applying electric shocks to the heart, e.g. for cardioversion

Abstract

In an implantable cardioverter-defibrillator and/or pacemaker, each having DDD pacing capabilities, an improved method of operation is described which dramatically increases the longevity of the implanted device by conserving battery power. The method comprises deactivating at least one unnecessary, power-consuming feature of the device until such feature is needed and then reactivating said feature only for so long as it is required by the patient. In a particular embodiment, the atrial sense amplifier is deactivated during normal operation of the implantable device, resulting in single-chamber sensing and pacing. Upon the occurrence of a predefined event, indicative of a need for dual-chamber sensing and pacing, the atrial sense amplifier is reactivated, the need for DDD pacing confirmed, and if appropriate, DDD pacing is begun. Once the patient'"'"'s heart rate has returned to an acceptable level, the atrial sense amplifier is again deactivated and single-chamber sensing/pacing continued. In addition, the atrial sense amplifier of an ICD/pacemaker is deactivated during normal operation of the device and reactivated immediately following the detection of ventricular tachycardia. In this embodiment, DDD sensing/pacing is preferably automatically begun following this detection. Also contemplated herein, are improved devices employing the improved methods.

Claims

1. In an implantable stimulation device having an atrial sense amplifier, a method of reducing power consumption comprising:

activating the atrial sense amplifier in response to an occurrence of a predetermined number of sequential ventricular pacing events;

monitoring heart activity; and

deactivating the atrial sense amplifier to reduce power consumption when the heart activity is within acceptable limits.

2. The method of claim 1, further comprising confirming a need for atrial sensing subsequent to activating the atrial sense amplifier and initiating an atrial sensing mode.

3. The method of claim 1, wherein:

the monitoring step comprises detecting a parameter related to ventricular activity; and

the deactivating step comprises detecting when the parameter related to ventricular activity is within the acceptable limits.

4. The method of claim 3, wherein the detecting when a parameter related to ventricular activity is within acceptable limits comprises at least one of:

detecting that a ventricular rate has returned to within predefined acceptable limits;

detecting that the ventricular rate is above a predetermined base rate;

detecting a P-R interval within the acceptable limits; and

detecting that a substantial number of P-waves are followed by respective R-waves which is indicative of a stable ventricular rate that no longer requires atrial sensing.